Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 5/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 4/20 | 0.35 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3170341 | 0.92 | MEN1 (0.43) | MEN1KMT2ACA2CA1CA12 | |
| SCHEMBL3165524 | 0.92 | MEN1 (0.43) | MEN1KMT2ACA2CA1CA12 | |
| SCHEMBL16371370 | 0.80 | RELA (0.45) | MEN1KMT2ACA2CA1CA12 | |
| SCHEMBL1724564 | 0.80 | POLB (0.41) | KMT2ACA2CA1CA12CA14 | |
| SCHEMBL18396375 | 0.79 | MEN1 (0.43) | MEN1KMT2ACA2CA1CA12 | |
| SCHEMBL18396373 | 0.79 | MEN1 (0.43) | MEN1KMT2ACA2CA1CA12 | |
| SCHEMBL25735982 | 0.78 | MEN1 (0.39) | MEN1KMT2ACA2CA1CA12 | |
| SCHEMBL13840434 | 0.77 | FABP4 (0.56) | MEN1KMT2AALDH1A1 | |
| SCHEMBL396581 | 0.76 | MEN1 (0.41) | MEN1KMT2ACA2CA1CA12 | |
| SCHEMBL3773841 | 0.75 | CA1 (0.43) | MEN1KMT2ACA2CA1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240122180-A1 | FUNGICIDAL HALOMETHYL KETONES AND HYDRATES AND THEIR MIXTURES | FMC CORPORATION | 2024-04-18 | — | — | US | disclosed |
| EP-2403834-A1 | Fungicidal pyrazoles | E. I. du Pont de Nemours and Company (US) | 2012-01-11 | — | — | EP | disclosed |
| WO-2010101973-A1 | FUNGICIDAL PYRAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240122180-A1 | FUNGICIDAL HALOMETHYL KETONES AND HYDRATES AND THEIR MIXTURES | AKR7A2, TBCA, TUBA1C | MEN1 3080/4885KMT2A 909/4885CA2 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.